183 related articles for article (PubMed ID: 10837485)
41. Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin).
Mosesson MW; DiOrio JP; Müller MF; Shainoff JR; Siebenlist KR; Amrani DL; Homandberg GA; Soria J; Soria C; Samama M
Blood; 1987 Apr; 69(4):1073-81. PubMed ID: 3548843
[TBL] [Abstract][Full Text] [Related]
42. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
Mihalyi E
Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
[TBL] [Abstract][Full Text] [Related]
43. Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.
Mihalyi E
Biochemistry; 1988 Feb; 27(3):976-82. PubMed ID: 3365374
[TBL] [Abstract][Full Text] [Related]
44. Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.
Okude M; Yamanaka A; Morimoto Y; Akihama S
Biol Pharm Bull; 1993 May; 16(5):448-52. PubMed ID: 8364489
[TBL] [Abstract][Full Text] [Related]
45. Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin.
Shainoff JR; Smejkal GB; DiBello PM; Sung SS; Bush LA; Di Cera E
J Biol Chem; 2002 May; 277(22):19367-73. PubMed ID: 11891217
[TBL] [Abstract][Full Text] [Related]
46. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
47. An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
Llobet D; Borrell M; Vila L; Vallvé C; Felices R; Fontcuberta J
Haematologica; 2007 Feb; 92(2):e17-9. PubMed ID: 17405747
[TBL] [Abstract][Full Text] [Related]
48. Thrombin-bound structures of designed analogs of human fibrinopeptide A determined by quantitative transferred NOE spectroscopy: a new structural basis for thrombin specificity.
Ni F; Zhu Y; Scheraga HA
J Mol Biol; 1995 Oct; 252(5):656-71. PubMed ID: 7563081
[TBL] [Abstract][Full Text] [Related]
49. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.
Cooper AV; Standeven KF; Ariëns RA
Blood; 2003 Jul; 102(2):535-40. PubMed ID: 12663453
[TBL] [Abstract][Full Text] [Related]
50. Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.
Ribes JA; Ni F; Wagner DD; Francis CW
J Clin Invest; 1989 Aug; 84(2):435-42. PubMed ID: 2788172
[TBL] [Abstract][Full Text] [Related]
51. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.
Mihalyi E; Tercero JC; Diaz-Mauriño T
Biochemistry; 1991 May; 30(19):4753-62. PubMed ID: 2029517
[TBL] [Abstract][Full Text] [Related]
52. Effect of bilineobin, a thrombin-like proteinase from the venom of common cantil (Agkistrodon bilineatus).
Komori Y; Nikai T; Ohara A; Yagihashi S; Sugihara H
Toxicon; 1993 Mar; 31(3):257-70. PubMed ID: 8470131
[TBL] [Abstract][Full Text] [Related]
53. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin.
De Cristofaro R; Castagnola M
Haemostasis; 1991; 21(2):85-90. PubMed ID: 1959802
[TBL] [Abstract][Full Text] [Related]
54. [Coagulation and fibrinolysis in chronic subdural hematoma. Measurement of fibrinopeptides].
Harada K; Orita T; Abiko S; Aoki H
Neurol Med Chir (Tokyo); 1989 Feb; 29(2):113-6. PubMed ID: 2475799
[TBL] [Abstract][Full Text] [Related]
55. Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.
Hanna LS; Scheraga HA; Francis CW; Marder VJ
Biochemistry; 1984 Sep; 23(20):4681-7. PubMed ID: 6238619
[TBL] [Abstract][Full Text] [Related]
56. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
Lewis SD; Shafer JA
Thromb Res; 1984 Jul; 35(2):111-20. PubMed ID: 6474412
[TBL] [Abstract][Full Text] [Related]
57. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: investigation of nine congenital fibrinogen abnormalities.
Southan C; Thompson E; Lane DA
Br J Haematol; 1987 Apr; 65(4):469-73. PubMed ID: 3580304
[TBL] [Abstract][Full Text] [Related]
58. Study on the thrombin-like enzyme preferentially releasing fibrinopeptide B from the snake venom of Agkistrodon halys Pallas.
Guan LF; Chi CW; Yuan M
Thromb Res; 1984 Aug; 35(3):301-10. PubMed ID: 6463961
[TBL] [Abstract][Full Text] [Related]
59. Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42.
Hamaguchi M; Bunce LA; Sporn LA; Francis CW
Blood; 1993 May; 81(9):2348-56. PubMed ID: 8481515
[TBL] [Abstract][Full Text] [Related]
60. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]